Recruiting Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL). NCT07503730 Conditions APL Locations First Affiliated Hospital of Xi'an Jiaotong University — Xi'an, Shaanxi, China View Trial Details
Recruiting Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia NCT05881265 Conditions APL Locations The Affiliated Huai An No 1 Perople's Hospital of NanJing University — Huai'an, Jiangsu, China The First Affiliated Hospital of Nanchang University — Nanchang, Jiangxi, China Jiong HU — Shanghai, Shanghai Municipality, China Zhaxin Hospital, Go Broad Health Care — Shanghai, Shanghai Municipality, China View more locations Show fewer locations Loading locations... View Trial Details
Not Yet Recruiting A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301) NCT07296445 Conditions APL, Acute Promyelocytic Leukaemia, Acute Promyelocytic Leukemia, +14 more Locations Not specified View Trial Details
